DNA methyltransferase 1 (DNMT1) is responsible for propagating the DNA methylation patterns during DNA replication. DNMT1 contains, in addition to a C-terminal methyltransferase domain, a large Nterminal regulatory region that is comprised of an RFTS (replication foci targeting sequence) domain, a CXXC zinc finger domain and a pair of BAH (bromo adjacent homology) domains. The regulatory domains of DNMT1 mediate a network of protein-protein and protein-DNA interactions to control the recruitment and enzymatic activity of DNMT1. Here we report the crystal structure of human DNMT1 with all the structural domains (hDNMT1, residues 351-1600) in complex with S-adenosyl-Lhomocysteine at 2.62 Å resolution. The RFTS domain directly associates with the methyltransferase domain, thereby inhibiting the substrate binding of hDNMT1. Through structural analysis, mutational, biochemical and enzymatic studies, we further identify that a linker sequence between the CXXC and BAH1 domains, aside from its role in the CXXC domain-mediated DNMT1 autoinhibition, serves as an important regulatory element in the RFTS domain-mediated autoinhibition. In comparison with the previously determined structure of mouse DNMT1, this study also reveals a number of distinct structural © 2015. This manuscript version is made available under the Elsevier user license
Introduction
DNA methylation is one of the key epigenetic mechanisms that are essential for transcriptional silencing of retrotransposons (1-3), genomic imprinting (4), and X-chromosome inactivation (5) . DNA methylation in mammals mainly occurs at the C-5 position of cytosine within the symmetric CpG dinucleotide and affects ~70-80% of the CpG dinucleotides throughout the genome (6) . The DNA methylation patterns are established by the de novo DNA methyltransferases DNMT3A and DNMT3B during gametogenesis and early embryogenesis, and become stably inherited by the maintenance DNA methyltransferase DNMT1, in cooperation with DNMT3A and DNMT3B (7) (8) (9) (10) . DNMT1-mediated maintenance DNA methylation is supported by both its substrate preference toward hemimethylated CpG sites (11, 12) , and its recruitment to DNA replication foci (13, 14) , through its interactions with proliferating cell nuclear antigen (PCNA) (15) and histone H3 ubiquitinated at lysine 23 (16) .
DNMT1 is a multi-modular protein that is comprised of ~1,620 amino acids. It contains a C-terminal methyltransferase (MTase) domain and a large N-terminal regulatory region, linked by a conserved (GK)n dipeptide repeat. The N-terminal region of DNMT1 is composed of an RFTS (replication foci targeting sequence) domain, a CXXC zinc finger domain, and a pair of BAH (bromo adjacent homology) domains. These N-terminal domains distinguish DNMT1 from its bacterial counterparts and impose a tight control on the recruitment and enzymatic activity of DNMT1 (7, 17) . To elucidate the regulatory mechanisms of DNMT1, we have previously determined the crystal structures of a C-terminal fragment of mouse DNMT1 (residues 650-1602, mDNMT1 ) in complex with an unmethylated CpG DNA, and the equivalent human DNMT1 (hDNMT1 646-1600 )-DNA complex, at 3.0 Å and 3.6 Å resolution, respectively (18) . These structures reveal that the DNMT1 CXXC domain specifically binds to the CpG 3 dinucleotide, which helps position the CXXC-BAH1 domain linker (a.k.a. autoinhibitory linker) into the catalytic cleft of the MTase domain, thereby forming an autoinhibitory conformation. This observation, together with mutational studies and enzymatic activity assays, suggests that the DNMT1 CXXC domain plays an inhibitory role in DNMT1-mediated de novo methylation. In a separate study, Takeshita et al (19) has determined the structure of a longer mDNMT1 fragment (residues 291-1620, mDNMT1 ), free and in complex with cofactor S-adenosyl-L-methionine (AdoMet) or cofactor product S-adenosyl-Lhomocysteine (AdoHcy). The structure of mDNMT1 reveals that the RFTS domain forms a DNA competitive inhibitor through direct interaction with the MTase domain of mDNMT1. This observation suggests that the RFTS domain plays an inhibitory role in DNMT1-mediated methylation, and has subsequently been supported by a number of biochemical and cellular studies (19) (20) (21) (22) .
Human DNMT1 and its mouse orthologue share about 80% sequence identity, which raises a question about whether the structure of mDNMT1 can fully recapitulate the functional state of hDNMT1. Indeed, previous enzymatic analysis of full-length recombinant hDNMT1 and mDNMT1 proteins over the poly(dI-dC).poly(dI-dC) substrates have revealed a 30-fold difference in their k cat values (23) (24) (25) . Our recent studies have also shown that mDNMT1 650-1602 and its human counterpart, hDNMT1 646-1600 , methylate a 14-mer hemimethylated CpG DNA with 2-3 fold different k cat and K m values (18) . Together, these observations suggest that subtle functional diversity may exist between the two orthologues. In addition, the relative low resolution (2.75 -3.25 Å) of the structure of mDNMT 291-1620 limited detailed analysis of protein interactions, such as the water-mediated hydrogen bonding. In this study, we report the crystal structure of a long C-terminal fragment of hDNMT1 (residues 351-1600, hDNMT1 351-1600 ) in complex with AdoHcy at 2.62 Å resolution. This structural study, combined with mutational, biochemical and enzymatic analysis, provides deep insights into the allosteric regulation of hDNMT1 and its structurefunction diversity from mDNMT1. Importantly, this study reveals that the DNMT1 CXXC-BAH1 domain linker plays an important role in two different autoinhibitory mechanisms of DNMT1. It also 4 provides a framework for understanding the functional effect of the disease-related mutations of hDNMT1.
Results
hDNMT1 adopts an autoinhibitory conformation similar to that of mDNMT1 291-1620 -The structure of hDNMT1 351-1600 reveals a closely-stacked three-layer architecture (Fig. 1A) , with the RFTS and CXXC domains on the top, the MTase domain in the middle, and the two BAH domains situated at the bottom.
In addition, it contains five zinc finger clusters, spreading over the RFTS domain, the CXXC domain, the BAH1 domain and the MTase domain, and an AdoHcy molecule in the active site (Fig. 1A) . The Nterminal domains, except for the CXXC domain, make extensive contacts with the MTase domain, resulting in a compact fold (Fig. 1A) . We have performed small X-ray scatting (SAXS) analysis to validate the observed structural fold (Fig. 1B) . Our results revealed that the structure of hDNMT1 fits well with the SAXS scatting curve, with a  2 of 1.4 (Fig. 1B) , thereby confirming that this structure is consistent with the conformation of hDNMT1 351-1600 in solution state.
The structure of hDNMT1 351-1600 reveals that its RFTS domain is anchored to the catalytic cleft of its MTase domain (the contacts are detailed below), potentially inhibiting the substrate binding (Fig. 1A) .
Such an autoinhibitory conformation is reminiscent of what was previously observed for mDNMT1 ( Fig. 1C ) (19) . In fact, the structures of hDNMT1 351-1600 and mDNMT1 291-1620 superimpose well, with a root-mean-square deviation (r.m.s.d.) of 1.0 Å over 989 aligned C atoms, consistent with the fact that these two orthologues share ~ 83% sequence identity in this region (Fig. S1 ). The main conformational difference between the two structures arises from the N-terminal half of the RFTS domain, which is associated with relatively lower (72%) sequence identity (Fig. S1 ). In particular, the -helix ( RS :
residues 495-519 in hDNMT1) that connects the two halves of the RFTS domain adopts a straight conformation in hDNMT1 351-1600 , but is kinked in the structure of mDNMT1 (Fig. 1C) . As a result, the orientation of the first half of the RFTS domain relative to the rest of the protein is deviated by 19 5 between hDNMT1 351-1600 and mDNMT1 (Fig. 1C) , despite the relatively conserved fold of this region. Such a conformational divergence between hDNMT1 351-1600 and mDNMT1 291-1620 is in attributed in part to their distinct molecular contacts within the RFTS domain (Fig. 1D,E) . In the structure of hDNMT1 351-1600 , loop residues F469, E473, K474, A475 and I477 from the RFTS domain make close contacts with residues F499, Q502, Y507 and K510 from the N-terminal part of the  RS -helix (Fig. 1D) .
Whereas in the structure of mDNMT1 291-1620 , the equivalent loop extends further toward the C-terminal end of the  RS -helix, engaging in a distinct set of interactions that involve loop residues: L472, F475, D476, E479 and V481, and the  RS -helix residues: I512, K516, E520 and Q523 (Fig. 1E ). In agreement with these conformational differences, fitting the structure of mDNMT1 (a region equivalent to hDNMT1 ) to the hDNMT1 SAXS curve gives a worse fit than hDNMT1, with  2 of 2.1 (Fig. S2 ).
The RFTS domain-mediated autoinhibition is supported by both direct domain-domain interactions and
the CXXC-BAH1 domain linker -The previous structure of mDNMT1 has revealed that four hydrogen bonds, formed by residues E531, D532, D554 and L593 from the RFTS domain and K537, R1576, S1495 and T1505 from the MTase domain, respectively, mediate the association of the RFTS domain with the MTase domain (19) . Inspection of the structure of hDNMT1 351-1600 not only confirms the existence of the equivalent interactions in hDNMT1 ( Fig. 2A) , but also reveals an hDNMT1-unique interaction that supports the contact between the RFTS and MTase domains: a hydrogen bond between residues D583 and K1535 of hDNMT1 . Such an interaction is absent in mDNMT1 due to the fact that the residue equivalent to D583 is replaced by an alanine (19) . In addition, the improved resolution of the structure of hDNMT1 351-1600 has allowed us to identify a number of inter-domain contacts that have failed to be detected in the previous structure of mDNMT1 (19) . For instance, we have identified that two water-mediated hydrogen bonds, formed by the side chain of D548 with the backbone amide nitrogen of M1535 and the side chain hydroxyl group of Y1515, respectively, help mediate the association of the RFTS domain with the MTase domain ( Fig. 2A ).
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Analysis of the structure of hDNMT1 351-1600 reveals that the linker -helix between the CXXC and BAH1 domains also plays a role in associating the RFTS domain with the MTase domain. On one side, this helix interacts with the RFTS domain, through hydrogen bonds formed by the side chain of residue D700 and the side chains of residues R582 and K586, and by the side chain of residue E703 and the side chain of residue R582 (Fig. 2B ). On the other side, this helix makes contacts with the MTase domain through hydrogen bonds formed by the side chain of residue D702 and the backbone and side chain of residue N1233, and a main chain hydrogen bond between residues D702 and M1235 ( 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 methylation in the lower strand, expressed as %methylation, based on the relative signal intensities observed for selected fragment ions for the two methylated DNA strands that exhibit unique m/z values.
In particular, we derived the %methylation by dividing the peak area found in the selected-ion chromatogram (SIC) for monitoring the four transitions corresponding to the formations of the [a 3 (Fig. 3B) . Despite the fact that the aforementioned peak area ratio may deviate to some extent from the %methylation of the lower stand due to the differences in ionization and fragmentation efficiencies of the two DNA strands, this method permits a direct comparison of the relative levels of methylation induced by wild-type or mutant hDNMT1 proteins. As shown in Fig. 3C , at 2 hr reaction time, we observed a ~69% increase in the methylation activity of hDNMT1 351-1600 by the R582E mutation. The methylation activity of hDNMT1 351-1600 becomes even higher when we further removed a patch of residues (residues 694-701; the resulting mutant is denoted as 694-701) in the helical linker (Fig. 3C ). These data confirm that the CXXC-BAH1 linker-mediated interactions are inhibitory to the enzymatic activity of DNMT1. Note that the methylation activity of the R582E mutant remains lower than that of an RFTS-free DNMT1 fragment, hDNMT1 646-1600 (Fig. S3C) , indicating that the direct interactions between the RFTS and MTase domains are also important for the RFTS domain-mediated autoinhibtion ( Fig. 2A) (20) (21) (22) . Next, we performed SAXS analysis to examine whether these mutations affect the conformational states of hDNMT1 351-1600 in solution (Fig. S4A-D) . We observe that the radius of gyration (Rg) of hDNMT1 351-1600 increases from 40.5 Å for wild-type protein to 48.0 Å for the R582E mutant, and to 60.8 Å for the 694-701 mutant, while its maximum dimension (Dmax) increases from 98 Å for wild-type protein to 163 Å for the R582E mutant, and to 194 Å for the 694-701 mutant ( Notably, the CXXC-BAH1 helical linker adopts an extended form in the structures of hDNMT1 in complex with an unmethylated 19-mer CpG DNA (18) and free hDNMT1 601-1600 (PDB: 2SWR), suggesting that a helix-to-loop conformational transition was induced by the removal of the RFTS domain (Fig. S5) . In both structures, this sequence is positioned along the catalytic cleft of hDNMT1 via its interaction with the MTase domain, thereby inhibiting the interaction between DNMT1 and DNA substrates (18) . The inhibitory role of the CXXC-BAH1 linker in hDNMT1 646-1600 is further supported by our observation that the hDNMT1 351-1600 694-701 mutant shows even higher methylation efficiency than hDNMT1 646-1600 (Fig. S3C) . Taken together, these observations suggest that the CXXC-BAH1 domain linker inhibits the enzymatic activity of DNMT1 through a multi-layered mechanism. (19) . Based on this observation, it has been proposed that binding of the cofactor AdoMet provides a mechanism in switching the side chain conformation of the catalytic cysteine in mDNMT1 (19) . Different from that of mDNMT1 291-1620 , the structure of hDNMT1 reveals that the active site cysteine, C1226, is poised to receive the target cytosine even in the presence of AdoHcy (Fig. 4A) , suggesting that AdoMet-binding does not serve as a switch for the side chain conformation of C1226 in hDNMT1. Structural comparison of AdoHcy-bound hDNMT1 351-1600 and mDNMT1 further indicates that such a conformational difference arises from the fact that residue C1226 in hDNMT1 experiences more steric repulsion from the phenyl group of the adjacent residue, 9 F1229, than its counterpart in mDNMT1 (Fig. 4A) . In fact, the conformation of the F1229 equivalent residue in mDNMT1 (F1232) is restrained by a hydrogen bond between the side chain of residue F1232 and the backbone of residue R1285; such a hydrogen bond is not formed in hDNMT1, since the residue equivalent to mDNMT1 R1285 is replaced by a lysine. These observations imply a different cofactor binding response in the catalytic site between hDNMT1 and mDNMT1. Interestingly, the conformation of the catalytic cysteine in hDNMT1 351-1600 is also different from that in the hDNMT1 646-1600 -DNA complex (Fig. 4B) . In the latter case, the CXXC-BAH1 domain linker occupies the DNA binding site, thereby pushing the side chain of residue C1226 away from the DNA binding pocket through steric hindrance.
Dynamic positioning of the CXXC domain between different functional states of hDNMT1 -
The CXXC domain in the structure of mDNMT1 291-1620 was only partially determined (19) , presumably due to the relatively low resolution and conformational dynamics. The improved resolution of the structure of hDNMT1 351-1600 in this study has permitted us to trace the entire CXXC domain (Fig. 1A and 4C) . On this basis, we were able to compare the structure of the CXXC domain in free hDNMT1 (this study) and in its DNA-bound form (18) , which reveals a surprisingly high conformational identity between the two forms of the CXXC domain (Fig. 4C) . In particular, the CpG-recognition loop of the CXXC domain is well poised for DNA binding even in free state, suggestive of a preconfigured, functional conformation adopted by the CXXC domain. On the other hand, a large repositioning of the CXXC domain occurred between these two alternative states: The CXXC domain is spatially proximal to the MTase domain in free hDNMT1 351-1600 , but shifts away by a distance of ~30 Å when a 19-mer unmethylated CpG DNA is bound (Fig. 4C) . As described above, such repositioning of the CXXC domain is coupled with a helix-toloop conformational transition for the linker sequence between the CXXC domain and the BAH1 domain, which then occupies the catalytic cleft to impose another layer of autoinhibition on DNMT1.
Structural analysis of the disease-related DNMT1 mutations -Recent evidence has revealed that mutations of DNMT1 are implicated in several neurological disorders (31) (32) (33) (34) , including hereditary sensory autonomic neurophathy with dementia and hearing loss (HSAN1E) and cerebella ataxia, deafness 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 and narcolepsy (ADCA-DN). These mutations mainly fall into the RFTS domain of DNMT1 (Fig. 5A ).
For instance, mutations of D490E, P491Y, Y495C and Y495H were identified in a number of HSAN1E kindreds (31, 32) ; whereas mutations of A554V, C580R, G589A and V590F were implicated in a cohort of ADCA-DN patients (33, 34) . Structural analysis of hDNMT1 suggests that some of these mutations may result in altered conformation and stability of DNMT1. For instance, the side chain hydroxyl group of residue Y495 forms a hydrogen bond with the main chain carbonyl oxygen of residue C420, which helps stabilize the orientation of  RS -helix in the RFTS domain (Fig. 5B) . Mutation of Y495C or Y495H may disrupt such an interaction, leading to structural and dynamic change of the  RShelix. In addition, residues A554 and V590 both participate in formation of a hydrophobic cluster (Fig.   5C ). Therefore, their respective mutations likely result in local structural perturbation of this region.
Consistently, a previous study has shown that the Y495C mutation leads to reduced protein stability and enzymatic activity, and aberrant DNA methylation patterns (32) . Further analysis of these disease-related mutations requires a detailed functional characterization of the RFTS domain of DNMT1.
Discussion
Recent structural and functional studies on DNMT1 have provided important insights into the allosteric regulation and substrate specificity of DNMT1 (18, (20) (21) (22) (35) (36) (37) . However, the fact that hDNMT1 and mDNMT1 show slightly different enzymatic properties (18, (23) (24) (25) raises a question about whether structural analysis of mDNMT1 is sufficient to reveal the functional states of hDNMT1. This study presents the structure of an hDNMT1 construct that is comprised of all its structural domains, which therefore provides a framework for understanding of the structure-function relationship of hDNMT1, as well as the relationship between hDNMT1 mutations and human diseases.
The DNMT1 N-terminal domains are important in regulating the recruitment and enzymatic activity of DNMT1. The RFTS domain has been identified as a protein interaction module that mediates the recruitment of DNMT1 to replication foci (14, 16) , and the interaction between DNMT1 and UHRF1 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 (20, 21, 38, 39) . However, the molecular basis underlying these regulations remains unknown. Our structural study reveals detailed molecular interactions between the RFTS domain and the MTase domain, which explains the autoinhibitory role of the RFTS domain in the enzymatic activity of hDNMT1. In addition, we observed a conformational difference of the RFTS domain between hDNMT1 351-1600 and mDNMT1 291-1620, which, despite the possible contribution of different crystallization conditions, implies subtle structural diversity between the two orthologues.
Structural analysis and biochemical assays of hDNMT1 and DNA substrates (18) . Together, these observations suggest that the CXXC-BAH1 domain linker, namely autoinhibitory linker, inhibits the enzymatic activity of DNMT1 through a multi-layered mechanism (Fig. 6) . Such inhibition of DNMT1 will be conceivably released when DNMT1 binds to hemimethylated CpG DNA substrates, accompanied by a large conformational rearrangement of the RFTS and CXXC domains (Fig. 6) , although the conformation of the autoinhibitory linker under this state is currently unknown.
In comparison with the structure of mDNMT1 , this study reveals a number of distinct structural features for hDNMT1, including its catalytic site. In mDNMT1, the active site cysteine faces away from the DNA binding pocket in the presence of AdoHcy, but turns to approach the position where the target cytosine is hosted in the presence of AdoMet. Based on these observations, it has been proposed that the active site cysteine of mDNMT1 switches from an inactive conformation to an active conformation upon binding to AdoMet, but returns back to an inactive conformation after the methylation reaction occurs (19) . By contrast, the side chain of the catalytic cysteine of hDNMT1 is poised to receive the target 12 cytosine even in the presence of AdoHcy. Therefore, the AdoMet/AdoHcy cofactor binding does not appear to provide a switching mechanism for the active site of hDNMT1. Such divergence in functional regulation of hDNMT1 and mDNMT1 likely contributes to their slightly different enzymatic behaviors (23) (24) (25) .
Materials and Methods

Protein expression and purification
The gene encoding hDNMT1 351 with > 95% purity, was concentrated to ~15 mg/ml and stored in a buffer containing 25 mM Tris-HCl (pH 7.5), 100 mM NaCl and 5 mM DTT at -80 °C.
Crystallization and structure determination 13
For crystallization, hDNMT1 351-1600 was first mixed with AdoHcy in a molar ratio of 1:1.5. The complex was then crystallized using sitting-drop vapor diffusion method by mixing 1.5 μl of hDNMT1 351-1600 sample and 1.5 μl of reservoir solution containing 100 mM MES, pH6.0, 50 mM CaCl 2 , and 45% PEG200 at 16°C. Crystals that grew into full size in three days were equilibrated in reservoir solution before flash-frozen in liquid nitrogen.
The X-ray diffraction data set for hDNMT1 were collected on the BL 5.0.1 beamline at the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory. The diffraction data were indexed, integrated and scaled using the HKL 2000 program. The structure of hDNMT1 351-1600 was solved using the molecular replacement method in PHASER (40) using the structure of mDNMT1 291-1620 (PDB 3AV4) as a search model. The resulting electron density revealed that there are two molecules of hDNMT1 351-1600 in each asymmetric unit (ASU). Further modeling of the hDNMT1 351-1600 was carried out using COOT (41) , and then subject to refinement using the PHENIX software package (42) . The same Rfree test set was used throughout the refinement. The B-factors were refined with individual B values. The statistics for data collection and structural refinement of hDNMT1 351-1600 is summarized in Table 1 .
Small Angle X-ray Scatting experiment (SAXS)
To measure the X-ray scatting curve, 2-6 mg/ml hDNMT1 351-1600 wild-type, R582E or 694-701 protein samples were dissolved in a buffer containing 20 mM Tris-HCl, pH 7.5, 250 mM NaCl and 5 mM DTT. The SAXS data were collected at the SYBIL beamline at ALS, Lawrence Berkeley National Laboratory, and processed using the ScÅtter software (https://bl1231.als.lbl.gov/scatter/). The scattering curves calculated from the crystal structures were fit with the experimental curve using the fast open- 
Enzymatic methylation kinetics assay 14
The DNMT1 cytosine-5 methylation assays were carried out in triplicates, using protocols described previously (26) . 30 pmol of 12-mer DNA duplex (upper strand: 5'-GAGGC m CGCCTGC-3'; lower strand:
5'-GCAGGCGGCCTC-3') was incubated with 15 nmol of S-adenosyl-L-methionine (New England
Biolabs, Ipswich, WA) and 3 pmol of wild-type hDNMT1 (or its R582E mutant) at 37 °C in a reaction buffer (50 mM Tris-HCl, 1 mM DTT, 5% glycerol, 100 μg/mL BSA, pH 7.5). After incubation for 0.5, 1.0, and 2.0 hr, the enzyme was inactivated by heating at 65°C for 20 min and removed by chloroform extraction, and the aqueous layer was subjected to LC-MS/MS analysis.
LC-MS/MS Analysis and Data Processing
The LC-MS/MS experiments were conducted on an LTQ linear ion-trap mass spectrometer (Thermo 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 
